Toward Constructing an Endophenotype Strategy for Bipolar Disorders

Biological Psychiatry

Volumn 60, Issue 2, 2006, Pages 93-105

  Hasler, Gregor ^a   Drevets, Wayne C ^a   Gould, Todd D ^a   Gottesman, Irving I ^b   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

biological marker; bipolar disorder; endophenotypic; families; genetics; Intermediate phenotype; twins

Indexed keywords

AMPHETAMINE; ANTICONVULSIVE AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; COCAINE; LITHIUM; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; TRYPTOPHAN; VALPROIC ACID;

AMINO ACID DEFICIENCY; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN SIZE; CINGULATE GYRUS; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DRUG EFFECT; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RISK; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEARNING DISORDER; MEMORY DISORDER; MOTIVATION; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; REWARD; SCHIZOPHRENIA; SLEEP DEPRIVATION; WHITE MATTER;

BIPOLAR DISORDER; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; GENOTYPE; HUMANS; PHENOTYPE; SLEEP DEPRIVATION;

EID: 33745786711     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.11.006     Document Type: Review

References (208)

1. Addington J., and Addington D. Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophr Res 23 (1997) 197-204
2. Ahearn E.P., Steffens D.C., Cassidy F., Van Meter S.A., Provenzale J.M., Seldin M.F., et al. Familial leukoencephalopathy in bipolar disorder. Am J Psychiatry 155 (1998) 1605-1607
3. Ahn K.H., Lyoo I.K., Lee H.K., Song I.C., Oh J.S., Hwang J., et al. White matter hyperintensities in subjects with bipolar disorder. Psychiatry Clin Neurosci 58 (2004) 516-521
4. Akiskal H.S., and Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 22 (1999) 517-534 vii
5. Altshuler L.L., Curran J.G., Hauser P., Mintz J., Denicoff K., and Post R. T2 hyperintensities in bipolar disorder. Magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 152 (1995) 1139-1144
6. Altshuler L.L., Ventura J., van Gorp W.G., Green M.F., Theberge D.C., and Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 56 (2004) 560-569
7. Anand A., Darnell A., Miller H.L., Berman R.M., Cappiello A., Oren D.A., et al. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. Biol Psychiatry 45 (1999) 972-978
8. Anand A., Verhoeff P., Seneca N., Zoghbi S.S., Seibyl J.P., Charney D.S., et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 157 (2000) 1108-1114
9. Angst J. Zur Ätiologie und Nosologie endogener depressiver Psychosen. Eine genetische, soziologische and klinische Studie (1966), Springer, Berlin
10. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50 (1998) 143-151
11. Angst J., Frey R., Lohmeyer B., and Zerbin-Rudin E. Bipolar manic-depressive psychoses. Results of a genetic investigation. Hum Genet 55 (1980) 237-254
12. Angst J., and Gamma A. A new bipolar spectrum concept. A brief review. Bipolar Disord 4 suppl 1 (2002) 11-14
13. Angst J., and Perris C. Zur Nosologie endogener Psychosen. Vergleich der Ergebnisse zweier Untersuchungen. Arch Psychiatr Nervenkr 210 (1968) 373-386
14. Angst J., and Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 146 (1995) 17-23
15. Angst J., Vollrath M., Merikangas K., and Ernst C. Comorbidity of anxiety and depression in the Zurich Cohort Study of Young Adults. In: Maser J.D., and Cloninger C.R. (Eds). Comorbidity of Mood and Anxiety Disorders (1990), American Psychiatric Press, Washington, DC 123-137
16. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7 (2002) 405-411
17. Bannerman D.M., Good M.A., Butcher S.P., Ramsay M., and Morris R.G. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature 378 (1995) 182-186
18. Barrett T.B., Hauger R.L., Kennedy J.L., Sadovnick A.D., Remick R.A., Keck P.E., et al. Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol Psychiatry 8 (2003) 546-557
19. Benedetti F., Bernasconi A., Lorenzi C., Pontiggia A., Serretti A., Colombo C., et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355 (2004) 37-40
20. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 123 (2003) 23-26
21. Benedetti F., Serretti A., Colombo C., Lorenzi C., Tubazio V., and Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368 (2004) 123-126
22. Berger M., Riemann D., Hochli D., and Spiegel R. The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?. Arch Gen Psychiatry 46 (1989) 421-428
23. Bertelsen A. Contributions of Danish registers to understanding psychopathology: Thirty years of collaboration with Irving I. Gottesman. In: DiLalla L.F. (Ed). Behavior Genetics Principles. Perspectives in Development, Personality, and Psychopathology (2004), American Psychological Association, Washington, DC 123-133
24. Blumberg H.P., Leung H.C., Skudlarski P., Lacadie C.M., Fredericks C.A., Harris B.C., et al. A functional magnetic resonance imaging study of bipolar disorder. State- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 60 (2003) 601-609
25. Boivin D.B., Czeisler C.A., Dijk D.J., Duffy J.F., Folkard S., Minors D.S., et al. Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry 54 (1997) 145-152
26. Botteron K.N., Raichle M.E., Drevets W.C., Heath A.C., and Todd R.D. Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biol Psychiatry 51 (2002) 342-344
27. Botteron K.N., Raichle M.E., Heath A.C., Price A., Sternhell K.E., Singer T.M., et al. An epidemiological twin study of prefrontal neuromorphometry in early onset depression. Biol Psychiatry 45 (1999) 59S
28. Bourtchuladze R., Frenguelli B., Blendy J., Cioffi D., Schutz G., and Silva A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79 (1994) 59-68
29. Bunney W.E., and Bunney B.G. Molecular clock genes in man and lower animals. Possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22 (2000) 335-345
30. Bunney Jr. W.E., Kopanda R.T., and Murphy D.L. Sleep and behavioral changes possibly reflecting central receptor hypersensitivity following catecholamine synthesis inhibition in man. Acta Psychiatr Scand 56 (1977) 189-203
31. Cannon D., Nugent A.C., Carson R.E., Williams J.M., Wood S., Solorio G., et al. Reduced muscarinic cholinergic2 receptor binding in bipolar disorder using PET and [F-18]FPTZTP. Biol Psychiatry 55 (2004) 229S
32. Carlson C.S., Eberle M.A., Kruglyak L., and Nickerson D.A. Mapping complex disease loci in whole-genome association studies. Nature 429 (2004) 446-452
33. Charney D.S., Barlow D.H., Botteron K.N., Cohen J.D., Goldman D., Gur R.C., et al. Neuroscience research agenda to guide development of a pathophysiologically based classification system. In: Kupfer D.J., First M.B., and Regier D.A. (Eds). A Research Agenda for DSM-V (2002), American Psychiatric Association, Washington, DC 31-83
34. Cirelli C., and Tononi G. Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J Neurosci 20 (2000) 9187-9194
35. Cirelli C., and Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res 885 (2000) 303-321
36. Clark L., and Goodwin G.M. State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 254 (2004) 61-68
37. Clark L., Iversen S.D., and Goodwin G.M. Sustained attention deficit in bipolar disorder. Br J Psychiatry 180 (2002) 313-319
38. Clark L., Kempton M.J., Scarna A., Grasby P.M., and Goodwin G.M. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol Psychiatry 57 (2005) 183-187
39. Clark L., Scarna A., and Goodwin G.M. Executive function but not memory is impaired in first-degree relatives of bipolar I patients and in euthymic unipolar depression. Am J Psychiatry 162 (2005) 1980-1982
40. Colombo C., Benedetti F., Barbini B., Campori E., and Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res 86 (1999) 267-270
41. Crabbe J.C., Jarvik L.F., Liston E.H., and Jenden D.J. Behavioral responses to amphetamines in identical twins. Acta Genet Med Gemellol (Roma) 32 (1983) 139-149
42. Craddock N., O'Donovan M.C., and Owen M.J. The genetics of schizophrenia and bipolar disorder. Dissecting psychosis. J Med Genet 42 (2005) 193-204
43. Damasio A.R., Tranel D., and Damasio H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res 41 (1990) 81-94
44. Dauvilliers Y., Maret S., and Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev 9 (2005) 91-100
45. Davis K.L., Berger P.A., Hollister L.E., and Defraites E. Physostigmine in mania. Arch Gen Psychiatry 35 (1978) 119-122
46. de Wit H., Uhlenhuth E.H., and Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16 (1986) 341-360
47. DePaulo Jr. J.R. Genetics of bipolar disorder. Where do we stand?. Am J Psychiatry 161 (2004) 595-597
48. Dilsaver S.C. Pathophysiology of "cholinoceptor supersensitivity" in affective disorders. Biol Psychiatry 21 (1986) 813-829
49. Diorio D., Viau V., and Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 13 (1993) 3839-3847
50. Doyle A.E., Willcutt E.G., Seidman L.J., Biederman J., Chouinard V.A., Silva J., et al. Attention-deficit/hyperactivity disorder endophenotypes. Biol Psychiatry 57 (2005) 1324-1335
51. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry 48 (2000) 813-829
52. Drevets W.C. Neuroimaging and neuropathological studies of depression. Implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11 (2001) 240-249
53. Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49 (2001) 81-96
54. Drevets W.C., Ongur D., and Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex. Implications for the pathophysiology of familial mood disorders. Mol Psychiatry 3220-3226 (1998) 190-191
55. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
56. Drevets W.C., Ryan N.D., Bogers W., Birmaher B., Axelson D., and Dahl R.E. Subgenual prefrontal cortex volume decreased in healthy humans at high familial risk for mood disorders. Soc Neuroscience Abstr 799 (2004) 19
57. D'Souza D.C., Berman R.M., Krystal J.H., and Charney D.S. Symptom provocation studies in psychiatric disorders. Scientific value, risks, and future. Biol Psychiatry 46 (1999) 1060-1080
58. Duncan Jr. W.C. Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther 71 (1996) 253-312
59. Dupont R.M., Butters N., Schafer K., Wilson T., Hesselink J., and Gillin J.C. Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Biol Psychiatry 38 (1995) 482-486
60. Dupont R.M., Jernigan T.L., Gillin J.C., Butters N., Delis D.C., and Hesselink J.R. Subcortical signal hyperintensities in bipolar patients detected by MRI. Psychiatry Res 21 (1987) 357-358
61. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
62. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
63. Einat H., Manji H.K., and Belmaker R.H. New approaches to modeling bipolar disorder. Psychopharmacol Bull 37 (2003) 47-63
64. Fan J., McCandliss B.D., Sommer T., Raz A., and Posner M.I. Testing the efficiency and independence of attentional networks. J Cogn Neurosci 14 (2002) 340-347
65. Fan J., Wu Y., Fossella J.A., and Posner M.I. Assessing the heritability of attentional networks. BMC Neurosci 2 (2001) 14
66. Farmer A.E., McGuffin P., and Gottesman I.I. Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. Arch Gen Psychiatry 44 (1987) 634-641
67. Ferrier I.N., Chowdhury R., Thompson J.M., Watson S., and Young A.H. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder. A preliminary report. Bipolar Disord 6 (2004) 319-322
68. First M.B., Pincus H.A., Levine J.B., Williams J.B., Ustun B., and Peele R. Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry 161 (2004) 946-954
69. Frangou S., Haldane M., Roddy D., and Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Biol Psychiatry 58 (2005) 838-839
70. Freimer N., and Sabatti C. The human phenome project. Nat Genet 34 (2003) 15-21
71. Freimer N., and Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet 36 (2004) 1045-1051
72. Fritze J., and Beckmann H. The cholinergic agonist RS 86. A pharmacopsychological study. Neuropsychobiology 19 (1988) 35-39
73. Fu Q., Heath A.C., Bucholz K.K., Nelson E., Goldberg J., Lyons M.J., et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence. Contribution of antisocial personality disorder in men. Arch Gen Psychiatry 59 (2002) 1125-1132
74. Fulton M.K., Armitage R., and Rush A.J. Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression. A pilot study. Biol Psychiatry 47 (2000) 618-625
75. George F.R., Porrino L.J., Ritz M.C., and Goldberg S.R. Inbred rat strain comparisons indicate different sites of action for cocaine and amphetamine locomotor stimulant effects. Psychopharmacology (Berl) 104 (1991) 457-462
76. Giasson B.I., and Lee V.M. Are ubiquitination pathways central to Parkinson's disease?. Cell 114 (2003) 1-8
77. Gillin J.C., Sitaram N., Mendelson W.B., and Wyatt R.J. Physostigmine alters onset but not duration of REM sleep in man. Psychopharmacology (Berl) 58 (1978) 111-114
78. Glahn D.C., Bearden C.E., Niendam T.A., and Escamilla M.A. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 6 (2004) 171-182
79. Goldberg T.E., and Weinberger D.R. Genes and the parsing of cognitive processes. Trends Cogn Sci 8 (2004) 325-335
80. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry. Etymology and strategic intentions. Am J Psychiatry 160 (2003) 636-645
81. Gottesman I.I., and Hanson D.R. Human development. Biological and genetic processes. Annu Rev Psychol 56 (2004) 10.1-10.24
82. Gottesman I.I., and Shields J. A polygenic theory of schizophrenia. Proc Natl Acad Sci U S A 58 (1967) 199-205
83. Gottesman I.I., and Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry 122 (1973) 15-30
84. Gould T.D., Chen G., and Manji H.K. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 29 (2004) 32-38
85. Gould T.D., and Manji H.K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 8 (2002) 497-511
86. Gourovitch M.L., Torrey E.F., Gold J.M., Randolph C., Weinberger D.R., and Goldberg T.E. Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 45 (1999) 639-646
87. Hakkarainen R., Johansson C., Kieseppa T., Partonen T., Koskenvuo M., Kaprio J., et al. Seasonal changes, sleep length and circadian preference among twins with bipolar disorder. BMC Psychiatry 3 (2003) 6
88. Hariri A.R., and Weinberger D.R. Imaging genomics. Br Med Bull 65 (2003) 259-270
89. Harmer C.J., Clark L., Grayson L., and Goodwin G.M. Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise. Neuropsychologia 40 (2002) 1586-1590
90. Harvey A.G., Schmidt D.A., Scarna A., Semler C.N., and Goodwin G.M. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry 162 (2005) 50-57
91. Hasler G., Buysse D.J., Klaghofer R., Gamma A., Ajdacic V., Eich D., et al. The association between short sleep duration and obesity in young adults. A 13-year prospective study. Sleep 27 (2004) 661-666
92. Hasler G., Drevets W.C., Manji H.K., and Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 29 (2004) 1765-1781
93. Hasler G., Pine D.S., Kleinbaum D.G., Gamma A., Luckenbaugh D., Ajdacic V., et al. Depressive symptoms during childhood and adult obesity. The Zurich Cohort Study. Mol Psychiatry 10 (2005) 842-850
94. Hirayasu Y., Shenton M.E., Salisbury D.F., Kwon J.S., Wible C.G., Fischer I.A., et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156 (1999) 1091-1093
95. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
96. Huey L.Y., Janowsky D.S., Judd L.L., Abrams A., Parker D., and Clopton P. Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes. Psychopharmacology (Berl) 73 (1981) 161-164
97. Jackson A., Cavanagh J., and Scott J. A systematic review of manic and depressive prodromes. J Affect Disord 74 (2003) 209-217
98. Janowsky D.S., el-Yousef M.K., and Davis J.M. Acetylcholine and depression. Psychosom Med 36 (1974) 248-257
99. Janowsky D.S., el-Yousef M.K., Davis J.M., and Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2 (1972) 632-635
100. Janowsky E.C., Risch C., and Janowsky D.S. Effects of anesthesia on patients taking psychotropic drugs. J Clin Psychopharmacol 1 (1981) 14-20
101. Johnson M.H., and Magaro P.A. Effects of mood and severity on memory processes in depression and mania. Psychol Bull 101 (1987) 28-40
102. Jones S.H., Hare D.J., and Evershed K. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disord 7 (2005) 176-186
103. Kajantie E., Rautanen A., Kere J., Andersson S., Yliharsila H., Osmond C., et al. The effects of the ACE gene insertion/deletion polymorphism on glucose tolerance and insulin secretion in elderly people are modified by birth weight. J Clin Endocrinol Metab 89 (2004) 5738-5741
104. Kasper S., and Wehr T.A. The role of sleep and wakefulness in the genesis of depression and mania. Encephale 18 spec no 1 (1992) 45-50
105. Katerina Z., Andrew K., Filomena M., and Xu-Feng H. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 29 (2004) 619-625
106. Kato T., Fujii K., Kamiya A., and Kato N. White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder. A preliminary observation. Psychiatry Clin Neurosci 54 (2000) 117-120
107. Kavoussi R.J., and Coccaro E.F. The amphetamine challenge test correlates with affective lability in healthy volunteers. Psychiatry Res 48 (1993) 219-228
108. Kendler K.S. Psychiatric genetics. A methodologic critique. Am J Psychiatry 162 (2005) 3-11
109. Kendler K.S., Ochs A.L., Gorman A.M., Hewitt J.K., Ross D.E., and Mirsky A.F. The structure of schizotypy. A pilot multitrait twin study. Psychiatry Res 36 (1991) 19-36
110. Keri S., Kelemen O., Benedek G., and Janka Z. Different trait markers for schizophrenia and bipolar disorder. A neurocognitive approach. Psychol Med 31 (2001) 915-922
111. Kieseppa T., Partonen T., Haukka J., Kaprio J., and Lonnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry 161 (2004) 1814-1821
112. Kim-Cohen J., Caspi A., Moffitt T.E., Harrington H., Milne B.J., and Poulton R. Prior juvenile diagnoses in adults with mental disorder. Developmental follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry 60 (2003) 709-717
113. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93 (1996) 8455-8459
114. Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacol Ther 56 (1992) 53-78
115. Klemfuss H., and Kripke D.F. Antimanic drugs stabilize hamster circadian rhythms. Psychiatry Res 57 (1995) 215-222
116. Knutson B., Adams C.M., Fong G.W., and Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21 (2001) RC159
117. Knutson B., Fong G.W., Bennett S.M., Adams C.M., and Hommer D. A region of mesial prefrontal cortex tracks monetarily rewarding outcomes. Characterization with rapid event-related fMRI. Neuroimage 18 (2003) 263-272
118. Lamberty Y., Margineanu D.G., and Klitgaard H. Effect of the new antiepileptic drug levetiracetam in an animal model of mania. Epilepsy Behav 2 (2001) 454-459
119. Lavori P.W., Krause-Steinrauf H., Brophy M., Buxbaum J., Cockroft J., Cox D.R., et al. Principles, organization, and operation of a DNA bank for clinical trials. A Department of Veterans Affairs cooperative study. Control Clin Trials 23 (2002) 222-239
120. Lenox R.H., Gould T.D., and Manji H.K. Endophenotypes in bipolar disorder. Am J Med Genet 114 (2002) 391-406
121. Levinson D.F., Levinson M.D., Segurado R., and Lewis C.M. Genome scan meta-analysis of schizophrenia and bipolar disorder, part I. Methods and power analysis. Am J Hum Genet 73 (2003) 17-33
122. Lewis M. Putting mind over matter. Rethinking current strategies for unmasking the genetics of mental illness. Clin Genet 66 (2004) 177
123. Linkowski P. Neuroendocrine profiles in mood disorders. Int J Neuropsychopharmacol 6 (2003) 191-197
124. Linkowski P., Van Onderbergen A., Kerkhofs M., Bosson D., Mendlewicz J., and Van Cauter E. Twin study of the 24-h cortisol profile. Evidence for genetic control of the human circadian clock. Am J Physiol 264 (1993) E173-E181
125. Luby J.L., Mrakotsky C., Heffelfinger A., Brown K., and Spitznagel E. Characteristics of depressed preschoolers with and without anhedonia. Evidence for a melancholic depressive subtype in young children. Am J Psychiatry 161 (2004) 1998-2004
126. Lyoo I.K., Lee H.K., Jung J.H., Noam G.G., and Renshaw P.F. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr Psychiatry 43 (2002) 361-368
127. Mamelak M. An amphetamine model of manic depressive illness. Int Pharmacopsychiatry 13 (1978) 193-208
128. Manji H.K., and Duman R.S. Impairments of neuroplasticity and cellular resilience in severe mood disorders. Implications for the development of novel therapeutics. Psychopharmacol Bull 35 (2001) 5-49
129. Manji H.K., Moore G.J., Rajkowska G., and Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5 (2000) 578-593
130. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K., A Gray N., et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53 (2003) 707-742
131. Martinek S., Inonog S., Manoukian A.S., and Young M.W. A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock. Cell 105 (2001) 769-779
132. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100 (2003) 6186-6191
133. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
134. Maziade M., Roy M.A., Chagnon Y.C., Cliche D., Fournier J.P., Montgrain N., et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder. A dense genome scan in Eastern Quebec families. Mol Psychiatry 10 (2005) 486-499
135. McDonald C., Bullmore E.T., Sham P., Suckling J., and MacCabe J. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder. Br J Psychiatry 186 (2005) 369-377
136. McDonald C., Bullmore E.T., Sham P.C., Chitnis X., Wickham H., Bramon E., et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 61 (2004) 974-984
137. McDonald C., Zanelli J., Rabe-Hesketh S., Ellison-Wright I., Sham P., Kalidindi S., et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 56 (2004) 411-417
138. McGue M., Gottesman I.I., and Rao D.C. The transmission of schizophrenia under a multifactorial threshold model. Am J Hum Genet 35 (1983) 1161-1178
139. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., and Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60 (2003) 497-502
140. McQueen M.B., Devlin B., Faraone S.V., Nimgaonkar V.L., Sklar P., Smoller J.W., et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 77 (2005) 582-595
141. Miyashita Y. Cognitive memory. Cellular and network machineries and their top-down control. Science 306 (2004) 435-440
142. Moisset B., and Welch B.L. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice. Experientia 29 (1973) 625-626
143. Moore P.B., El-Badri S.M., Cousins D., Shepherd D.J., Young A.H., McAllister V.L., et al. White matter lesions and season of birth of patients with bipolar affective disorder. Am J Psychiatry 158 (2001) 1521-1524
144. Murray C.L., and Fibiger H.C. Learning and memory deficits after lesions of the nucleus basalis magnocellularis. Reversal by physostigmine. Neuroscience 14 (1985) 1025-1032
145. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 suppl 1 (2004) 24-32
146. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
147. Nestler E.J., Barrot M., and Self D.W. DeltaFosB. A sustained molecular switch for addiction. Proc Natl Acad Sci U S A 98 (2001) 11042-11046
148. Nurnberger Jr. J., Berrettini W., Mendelson W., Sack D., and Gershon E.S. Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients. Biol Psychiatry 25 (1989) 610-617
149. Nurnberger Jr. J., Sitaram N., Gershon E.S., and Gillin J.C. A twin study of cholinergic REM induction. Biol Psychiatry 18 (1983) 1161-1165
150. Nurnberger Jr. J.I., Gershon E.S., Simmons S., Ebert M., Kessler L.R., Dibble E.D., et al. Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and 'well-state' bipolar patients. Psychoneuroendocrinology 7 (1982) 163-176
151. Nurnberger Jr. J.I., Jimerson D.C., Simmons-Alling S., Tamminga C., Nadi N.S., Lawrence D., et al. Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients. Psychiatry Res 9 (1983) 191-200
152. Ogden C.A., Rich M.E., Schork N.J., Paulus M.P., Geyer M.A., Lohr J.B., et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders. An expanded convergent functional genomics approach. Mol Psychiatry 9 (2004) 1007-1029
153. Öngür D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95 (1998) 13290-13295
154. Padiath Q.S., Paranjpe D., Jain S., and Sharma V.K. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol Int 21 (2004) 43-55
155. Peet M., and Peters S. Drug-induced mania. Drug Saf 12 (1995) 146-153
156. Perris C. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. VI. Studies in perception: a) colour-form preference. Acta Psychiatr Scand Suppl 194 (1966) 92-101
157. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions. A genetic susceptibility mechanism for depression. Nat Neurosci 8 (2005) 828-834
158. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24 (2004) 10099-10102
159. Picciotto M.R. Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend 51 (1998) 165-172
160. Pillai J.J., Friedman L., Stuve T.A., Trinidad S., Jesberger J.A., Lewin J.S., et al. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder. Psychiatry Res 114 (2002) 51-56
161. Plomin R., and Spinath F.M. Intelligence. Genetics, genes, and genomics. J Pers Soc Psychol 86 (2004) 112-129
162. Quintin P., Benkelfat C., Launay J.M., Arnulf I., Pointereau-Bellenger A., Barbault S., et al. Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder. Biol Psychiatry 50 (2001) 184-190
163. Raisman R., Briley M., and Langer S.Z. Specific tricyclic antidepressant binding sites in rat brain. Nature 281 (1979) 148-150
164. Risch S.C., Kalin N.H., and Janowsky D.S. Cholinergic challenges in affective illness. Behavioral and neuroendocrine correlates. J Clin Psychopharmacol 1 (1981) 186-192
165. Rybakowski J.K., Borkowska A., Czerski P.M., Skibinska M., and Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5 (2003) 468-472
166. Schultz W. Getting formal with dopamine and reward. Neuron 36 (2002) 241-263
167. Seidman L.J., Kremen W.S., Koren D., Faraone S.V., Goldstein J.M., and Tsuang M.T. A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr Res 53 (2002) 31-44
168. Sitaram N., Dube S., Keshavan M., Davies A., and Reynal P. The association of supersensitive cholinergic REM-induction and affective illness within pedigrees. J Psychiatr Res 21 (1987) 487-497
169. Sitaram N., Moore A.M., and Gillin J.C. The effect of physostigmine on normal human sleep and dreaming. Arch Gen Psychiatry 35 (1978) 1239-1243
170. Sitaram N., Moore A.M., and Gillin J.C. Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature 274 (1978) 490-492
171. Sitaram N., Moore A.M., and Gillin J.C. Induction and resetting of REM sleep rhythm in normal man by arecholine. Blockade by scopolamine. Sleep 1 (1978) 83-90
172. Sitaram N., Moore A.M., and Gillin J.C. Scopolamine-induced muscarinic supersensitivity in normal man. Changes in sleep. Psychiatry Res 1 (1979) 9-16
173. Sitaram N., Nurnberger Jr. J.I., Gershon E.S., and Gillin J.C. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. Science 208 (1980) 200-202
174. Sitaram N., Nurnberger Jr. J.I., Gershon E.S., and Gillin J.C. Cholinergic regulation of mood and REM sleep. Potential model and marker of vulnerability to affective disorder. Am J Psychiatry 139 (1982) 571-576
175. Sobczak S., Honig A., Nicolson N.A., and Riedel W.J. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls. Neuropsychopharmacology 27 (2002) 834-842
176. Sobczak S., Honig A., Schmitt J.A., and Riedel W.J. Pronounced cognitive deficits following an intravenous L-tryptophan challenge in first-degree relatives of bipolar patients compared to healthy controls. Neuropsychopharmacology 28 (2003) 711-719
177. Sobczak S., Riedel W.J., Booij I., Aan Het Rot M., Deutz N.E., and Honig A. Cognition following acute tryptophan depletion. Difference between first-degree relatives of bipolar disorder patients and matched healthy control volunteers. Psychol Med 32 (2002) 503-515
178. Sokolski K.N., and DeMet E.M. Pupillary cholinergic sensitivity to pilocarpine increases in manic lithium responders. Biol Psychiatry 45 (1999) 1580-1584
179. Sokolski K.N., and DeMet E.M. Cholinergic sensitivity predicts severity of mania. Psychiatry Res 95 (2000) 195-200
180. Souetre E., Salvati E., Wehr T.A., Sack D.A., Krebs B., and Darcourt G. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry 145 (1988) 1133-1137
181. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
182. Stanton T., Bolden-Watson C., Cusack B., and Richelson E. Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics. Biochem Pharmacol 45 (1993) 2352-2354
183. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
184. Stewart J., and Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4 (1993) 289-312
185. Stohr T., Schulte Wermeling D., Weiner I., and Feldon J. Rat strain differences in open-field behavior and the locomotor stimulating and rewarding effects of amphetamine. Pharmacol Biochem Behav 59 (1998) 813-818
186. Stoll A.L., Renshaw P.F., Yurgelun-Todd D.A., and Cohen B.M. Neuroimaging in bipolar disorder. What have we learned?. Biol Psychiatry 48 (2000) 505-517
187. Sullivan R.M., and Gratton A. Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. J Neurosci 19 (1999) 2834-2840
188. Swan G.E., and Carmelli D. Evidence for genetic mediation of executive control. A study of aging male twins. J Gerontol B Psychol Sci Soc Sci 57 (2002) P133-P143
189. Swan G.E., Reed T., Jack L.M., Miller B.L., Markee T., Wolf P.A., et al. Differential genetic influence for components of memory in aging adult twins. Arch Neurol 56 (1999) 1127-1132
190. Szuba M.P., Baxter Jr. L.R., Fairbanks L.A., Guze B.H., and Schwartz J.M. Effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression. Biol Psychiatry 30 (1991) 817-829
191. Szymusiak R. Magnocellular nuclei of the basal forebrain. Substrates of sleep and arousal regulation. Sleep 18 (1995) 478-500
192. Toh K.L., Jones C.R., He Y., Eide E.J., Hinz W.A., Virshup D.M., et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291 (2001) 1040-1043
193. Tremblay L.K., Naranjo C.A., Cardenas L., Herrmann N., and Busto U.E. Probing brain reward system function in major depressive disorder. Altered response to dextroamphetamine. Arch Gen Psychiatry 59 (2002) 409-416
194. Tripathy D., Lindholm E., Isomaa B., Saloranta C., Tuomi T., and Groop L. Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband. Am J Physiol Endocrinol Metab 285 (2003) E1297-E1303
195. Tsuang M.T., Faraone S.V., and Lyons M.J. Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Clin Neurosci 243 (1993) 131-142
196. Uhlenhuth E.H., Johanson C.E., Kilgore K., and Kobasa S.C. Drug preference and mood in humans. preference for d-amphetamine and subject characteristics. Psychopharmacology (Berl) 74 (1981) 191-194
197. van Gorp W.G., Altshuler L., Theberge D.C., Wilkins J., and Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 55 (1998) 41-46
198. Van Kammen D.P., and Murphy D.L. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44 (1975) 215-224
199. Vawter M.P., Freed W.J., and Kleinman J.E. Neuropathology of bipolar disorder. Biol Psychiatry 48 (2000) 486-504
200. Videbech P. MRI findings in patients with affective disorder. A meta-analysis. Acta Psychiatr Scand 96 (1997) 157-168
201. Wehr T.A., Sack D.A., and Rosenthal N.E. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 144 (1987) 201-204
202. Weiland-Fiedler P., Erickson K., Waldeck T., Luckenbaugh D.A., Pike D., Bonne O., et al. Evidence for continuing neuropsychological impairments in depression. J Affect Disord 82 (2004) 253-258
203. Wesnes K., and Warburton D.M. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl) 82 (1984) 147-150
204. Wirz-Justice A., and Van den Hoofdakker R.H. Sleep deprivation in depression. What do we know, where do we go?. Biol Psychiatry 46 (1999) 445-453
205. Wu J.C., and Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse. Review and hypothesis. Am J Psychiatry 147 (1990) 14-21
206. Zalla T., Joyce C., Szoke A., Schurhoff F., Pillon B., Komano O., et al. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 121 (2004) 207-217
207. Zammit S., Jones G., Jones S.J., Norton N., Sanders R.D., Milham C., et al. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am J Med Genet 128B (2004) 19-20
208. Zubieta J.K., Huguelet P., O'Neil R.L., and Giordani B.J. Cognitive function in euthymic bipolar I disorder. Psychiatry Res 102 (2001) 9-20